D-Wave Quantum's Order Book Jumps 668% — But the Stock Still Can't Escape IonQ's Shadow

D-Wave slid 5.7% as IonQ's $1.3B all-stock Elisity deal reignited dilution worries, despite D-Wave's $546.2M cash and 668% backlog jump.

When a heavyweight in an emerging industry reaches for its checkbook, the whole neighborhood feels the draft. That's precisely what happened to quantum computing stocks this week, after IonQ unveiled plans to swallow cybersecurity firm Elisity in an all-stock transaction worth up to $1.3 billion.

The dilution alarm bells rang immediately. IonQ's own shares bore the brunt, but the pain spread across the sector — and D-Wave Quantum was swept up in the tide. The stock shed 5.7% during Monday's US session, with a separate reading putting the decline at 5.2% to EUR 12.32. By today's European trading, the paper was changing hands at EUR 12.22.

Yet treating D-Wave as collateral damage tells only part of the story — and it obscures a far more interesting split between what the market is pricing and what the company is actually building.

A Sector That Flinches at the First Sign of New Shares

The reflexive selling exposes a familiar soft spot. Investors in quantum pioneers remain extraordinarily twitchy about anything touching financing or valuation. When a sector bellwether like IonQ has to dig deep into its own equity stash to fund an acquisition, doubts about the capital needs of the entire industry surface within minutes. The logic is simple enough: once growth gets financed by issuing fresh shares, existing holders start bracing for dilution.

Media coverage of the IonQ move has raised broader questions about how quantum companies are valued and how much funding they genuinely require. D-Wave getting caught in that downdraft is psychologically understandable — it says plenty about how tightly sentiment binds this corner of the tech sector — but it deserves a more measured reading.

The Balance Sheet Doesn't Match the Panic

Consider what D-Wave is actually sitting on. Cash and marketable securities totaled $546.2 million as of the end of June. That's not a company staring down a capital crunch or being forced into fire sales. The dilution anxiety triggered by a competitor's deal says almost nothing about D-Wave's own financial footing.

The operating picture, to be fair, is no walk in the park. Second-quarter 2026 revenue barely budged from a year earlier, stuck at $3.1 million. System sales and other revenue contributed just $300,000 of that total. The adjusted EBITDA loss widened 85% year over year, and gross margin slipped from 63.8% to 55.4%. Anyone hunting for quick operating profits is misreading the development stage this technology is still in.

Where the Real Story Lives

Look forward, though, and the picture brightens considerably. Cloud subscription revenue climbed 50% year over year in the second quarter, while professional services grew more than 18%.

The standout figure sits in the backlog. As of June 30, it had rocketed to $40.7 million — a gain of 668% compared with the prior year. Management says roughly 57% of that volume should convert into revenue within twelve months, and two system deliveries are slated for the current year. That combination ought to put meaningful acceleration behind the top line.

The technology roadmap is moving in parallel. D-Wave landed a $1.5 million grant from the National Science Foundation for ERASE, a fault-tolerant research project at Yale University. It also opened a beta phase for its in-house gate-model quantum simulator, with partners already testing the platform — even if large-scale, fully fault-tolerant gate systems for commercial use remain somewhere over the horizon. A separate collaboration with the Supply Chain Management Research Center at the University of Arkansas will explore quantum solutions for logistics problems through a support fund.

A Valuation That Leaves No Room for Slips

None of this changes the uncomfortable math. The stock has lost 46% since the start of the year and trades 70% below its 52-week high. Even after that bruising correction, it still commands an extraordinarily rich multiple of current revenue — a valuation that forgives no operational delays.

That's the crux of the D-Wave dilemma. The liquidity cushion is intact, the order book is filling fast, and the partnership network keeps expanding. But the gap between promise and revenue remains wide, and the shares stay hostage to every mood swing in the sector — even when D-Wave itself is operationally uninvolved.

If management delivers the promised systems on schedule and converts that backlog into actual sales over the coming quarters, fundamental progress should eventually outweigh the sector's jitters. Until that proof arrives, this remains a highly volatile name that demands patience above all else.